REGULATORY DETERMINANTS OF CANNABIS OUTCOMES SURVEY
National and State-Specific Outcomes of Cannabis Trends and Policy Outcomes Provided on a Quarterly Basis
The proliferation of cannabis legalization across the U.S. has created a pressing need for data and research that identifies how regulated access of cannabis could impact public health, economic and equity outcomes. How do outcomes differ between states and across markets, and how can we apply those findings across public health, behavioral economics, and markets, to institute policies that mitigate harms and amplify societal gains? Meet the Regulatory Determinants of Cannabis Outcomes Survey.
Our Regulatory Determinants of Cannabis Outcomes Survey (RDCOS) is conducted quarterly, and addresses the research gap with diverse, timely, and technical cannabis data. It identifies differences in cannabis-related outcomes
RDCOS per Quarter by the Numbers:*
50 number of states assesses for cannabis-related outcomes
10,000 approximate number of participants who use cannabis at least annually
200 number of cannabis-related outcomes of interest assessed
20 number of policy impact areas (Taxation, Licensing, Exc.)
*Starting in November 2022
The RDCOS is the only available tool that integrates population-level cannabis outcomes data in all 50 states with extensive policy data at state and substate levels. Review our survey questions to see how we leverage that data to evaluate policy success from several lenses. There is no shortage of insights for regulators, governments, researchers, cannabis-adjacent business, and other stakeholders alike.
Coming Soon: In 2023, all 50 U.S. will be included in the RDCOS. While the survey is already the most up-to-date, largest, and inferential analysis of cannabis policies and outcomes, next year we will offer even more inclusive data to assess cannabis market, economic, public health, and equity outcomes